Taylor, Cottrill, Erickson & Associates, Inc. Quanterix Corp Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$359 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 03, 2022	SELL	$37.54 - $57.51 $319,277 - $489,122	-8,505 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$45.91 - $59.67 $390,464 - $507,493	8,505 New	8,505 $423,000

Others Institutions Holding QTRX

# of Institutions

155

Shares Held

33.2M

Call Options Held

30.6K

Put Options Held

25.1K

Alliancebernstein L.P. New York, NY

3.27M
Shares

$37.7 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.14M
Shares

$36.2 Million
0.0% of portfolio
Portolan Capital Management, LLC Boston, MA

2.52M
Shares

$29.1 Million
2.6% of portfolio
Vanguard Group Inc Valley Forge, PA

2.2M
Shares

$25.3 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.06M
Shares

$23.8 Million
0.01% of portfolio

View Full List

About Quanterix Corp

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $426M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

More about QTRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account